QIAGEN announces European launch of QIAstat-Dx, a next generation platform for syndromic insights

Posters by early adopters demonstrate accurate, fast, cost-effective and flexible diagnosis of syndromic infections and other diseases in unique and versatile Sample to Insight workflows QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today ...